middle.news
How Will Opthea Rebound After Dropping Wet AMD Drug and Settling Funding Deal?
4:45am on Saturday 30th of August, 2025 AEST
•
Healthcare
Read Story
How Will Opthea Rebound After Dropping Wet AMD Drug and Settling Funding Deal?
4:45am on Saturday 30th of August, 2025 AEST
Key Points
Revenue up 57.9% to US$5.56 million
Net loss narrowed 26% to US$162.8 million
Discontinued sozinibercept development after negative Phase III results
Settled Development Funding Agreement with US$20 million payment and 9.99% equity issuance
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Opthea (ASX:OPT)
OPEN ARTICLE